Sector consensus Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Berne S.E.
28/09/2026
|
5-day change | 1st Jan Change | ||
| 243.60 CHF | +0.92% |
|
+6.87% | - |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 688.17 | +17.8% | 23 | ||||||
| 279.56 | +3.17% | 18 | ||||||
| 256.71 | +27.25% | 23 | ||||||
| 432.8 | +17.93% | 28 | ||||||
| 267,786.94 | +50.19% | 22 | ||||||
| 581.83 | -5.54% | 12 | ||||||
| 68.56 | -19.42% | 18 | ||||||
| 72.24 | -8.23% | 14 | ||||||
| 272.41 | +34.94% | 20 | ||||||
| 301.29 | +2.27% | 14 | ||||||
| 185.25 | +5.51% | 16 | ||||||
| 3.908 | -27.01% | 7 | ||||||
| 70.73 | -2.46% | 11 | ||||||
| 50.57 | +17.26% | 11 | ||||||
| 138.64 | +23.78% | 22 | ||||||
| 174.69 | +22.64% | 13 | ||||||
| 46.27 | +2.79% | 15 | ||||||
| 135.01 | +61.01% | 7 | ||||||
| 638.68 | +123.59% | 19 | ||||||
| Average | 14,325.49 | +18.29% | 16 | ||||||
| Weighted average by Cap. | 21,497.18 | +16.76% | 19 |
Select your edition
All financial news and data tailored to specific country editions
